Hospital
Jane Todd Crawford Memorial Hospital INC.
Jane Todd Crawford Memorial Hospital INC. was paid $7.65M by Medicaid between Jan 2018 and Dec 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.
33Billing provider infoJANE TODD CRAWFORD MEMORIAL HOSPITAL INC.
GREENSBURG, KY 42743
GREENSBURG, KY 42743
33aNPI1225161524assigned 03/14/2007
33bProvider typeCritical Access Hospital
28Total paid$7.65M
24GClaims148,611
24DCodes billed92
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Kentucky
Rank by total paid#14 of 16
Median peer was paid$11.73M
This provider vs. median0.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,178 | $809K | |
| 2019 | 18,887 | $759K | |
| 2020 | 15,625 | $669K | |
| 2021 | 23,172 | $1.26M | |
| 2022 | 23,554 | $1.31M | |
| 2023 | 25,083 | $1.51M | |
| 2024incomplete | 22,112 | $1.33M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 14% | 6,800 | 6,003 | $1.08M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 13% | 6,062 | 5,109 | $1.00M |
| 71046 | Radiologic examination, chest; 2 views | 6.2% | 4,383 | 3,398 | $476K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.0% | 835 | 592 | $382K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.9% | 10,891 | 9,319 | $379K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.8% | 1,463 | 1,184 | $368K |
| 71250 | 4.8% | 541 | 415 | $368K | |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.1% | 1,429 | 1,043 | $312K |
| 80053 | Comprehensive metabolic panel | 3.9% | 10,738 | 9,105 | $297K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3.2% | 3,315 | 2,352 | $244K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.7% | 3,732 | 3,127 | $203K |
| 36415 | Collection of venous blood by venipuncture | 2.4% | 27,528 | 13,740 | $186K |
80 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 2.1% | 3,811 | $165K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.1% | 2,656 | $159K |
| 80061 | Lipid panel | 1.8% | 2,902 | $137K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.7% | 6,040 | $130K |
| 82607 | 1.6% | 2,300 | $119K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.3% | 1,355 | $103K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.2% | 3,935 | $95K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 1,900 | $83K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.0% | 1,980 | $78K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,494 | $75K |
| 71045 | Radiologic examination, chest; single view | <1% | 567 | $64K |
| 83735 | <1% | 2,530 | $61K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 2,634 | $60K |
| 84484 | <1% | 2,371 | $56K | |
| 84439 | <1% | 1,469 | $50K | |
| 73630 | <1% | 297 | $48K | |
| 81001 | <1% | 2,403 | $48K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,127 | $47K |
| 84703 | <1% | 981 | $47K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 2,484 | $46K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 80 | $41K |
| 80306 | <1% | 613 | $39K | |
| 82550 | <1% | 2,109 | $34K | |
| 73610 | <1% | 199 | $33K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 283 | $30K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 73 | $29K |
| 82150 | <1% | 1,545 | $28K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 431 | $28K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 501 | $27K |
| 83690 | <1% | 1,618 | $26K | |
| 82553 | <1% | 1,662 | $26K | |
| 82043 | <1% | 718 | $24K | |
| 82803 | <1% | 229 | $24K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,083 | $22K |
| 72100 | <1% | 208 | $22K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 445 | $21K |
| 73562 | <1% | 152 | $21K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,048 | $19K |
| 73130 | <1% | 106 | $16K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 199 | $15K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 132 | $14K |
| 83540 | <1% | 323 | $14K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 138 | $13K |
| 82746 | <1% | 192 | $10K | |
| 85610 | <1% | 361 | $9K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,055 | $8K |
| 73030 | <1% | 56 | $8K | |
| 0011A | <1% | 126 | $7K | |
| 83550 | <1% | 82 | $7K | |
| 85027 | <1% | 502 | $6K | |
| 87081 | <1% | 1,385 | $5K | |
| 36600 | <1% | 160 | $5K | |
| 82728 | <1% | 93 | $5K | |
| 80074 | <1% | 40 | $4K | |
| 87070 | <1% | 43 | $4K | |
| 87807 | <1% | 70 | $4K | |
| 0012A | <1% | 74 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,649 | $4K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 45 | $4K |
| 91322 | <1% | 17 | $3K | |
| 83880 | <1% | 46 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 85 | $3K |
| 85379 | <1% | 17 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 433 | $2K |
| 87040 | <1% | 28 | $2K | |
| 81003 | <1% | 712 | $2K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 76 | $2K |
| 85652 | <1% | 88 | $2K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 72 | $815.05 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 29 | $777.63 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 42 | $559.10 |
| 86038 | <1% | 12 | $510.70 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 13 | $466.79 |
| 85730 | <1% | 32 | $458.87 | |
| 83605 | <1% | 30 | $436.14 | |
| 94664 | <1% | 14 | $379.20 | |
| 86803 | <1% | 27 | $196.19 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 20 | $169.11 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 12 | $30.39 |
| Q2037 | Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTUNGATE, REX (ADMINISTRATOR)
| Provider | Location | Paid |
|---|---|---|
| Casey County Hospital District | Liberty, KY | $11.12M |
| Casey County Hospital District | Liberty, KY | $1.34M |
| Jane Todd Crawford Memorial Hospital, INC. | Greensburg, KY | $1.33M |
| Casey County Hospital District | Liberty, KY | $1.04M |
| Jane Todd Crawford Memorial Hospital, INC. | Greensburg, KY | $590K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.